1 Matching Annotations
  1. Jul 2024
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
    1
    1. scibot 03 Jul 2024
      RRID: CVCL_4972

      DOI: 10.7150/thno.92646

      Resource: (RRID:CVCL_4972)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_4972

      What is this?
      RRID:CVCL_4972 DOI:10.7150/thno.92646
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11209725/